Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CNR1


Brief Information

Name:Cannabinoid CB1 receptor
Target Synonym:Cannabinoid Receptor 1 (Brain),CNR1,Cannabinoid Receptor 1,CANN6,CB-R,CNR,CB1,Central Cannabinoid Receptor,CB1K5,CB1A,CB1R,Receptor, Cannabinoid, CB1
Number of Launched Drugs:2
Number of Drugs in Clinical Trials:22
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CN1-H52P6 Human Human CNR1 Full Length Protein (VLP)
ACRO Quality

Part of Bioactivity data


Immobilized Human CNR1 Full Length Protein-VLP (Cat. No. CN1-H52P6) at 5 μg/mL (100 μL/well) can bind Human Anti-CNR1,Human IgG4 | Human Kappa with a linear range of 1-31 ng/mL (QC tested).

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Cannabidiol/Dronabinol THC-5; delta-9-THC/CBD; MPL-001; MPL-005; GW-1000; KL16-012; BOL-DP-o-04; GW-1000-02; PPP-001; MGC-ODT Approved Gw Pharmaceuticals Sativex, Qixleef Canada Muscle Spasticity; Multiple Sclerosis; Neuralgia; Cancer Pain; Chronic Pain null 2005-04-01 Arthritis, Psoriatic; Phobia, Social; Urinary Bladder, Overactive; Tic Disorders; Reflex Sympathetic Dystrophy; Huntington Disease; Muscle Spasticity; Neuromyelitis Optica; Sciatica; Malnutrition; Acute Pain; Tourette Syndrome; Dementia; Neuralgia; Panic Disorder; Stress Disorders, Post-Traumatic; Hepatic Insufficiency; Osteoarthritis, Knee; Back Pain; Drug Resistant Epilepsy; Hidradenitis Suppurativa; Agoraphobia; Renal Insufficiency, Chronic; Social Behavior; Low Back Pain; Cerebral Palsy; Corticobasal degeneration; Depression; Peripheral Nervous System Diseases; Sleep Initiation and Maintenance Disorders; Pain; Anxiety; Spinal Cord Injuries; Cancer Pain; Chronic Pain; Marijuana Use; Spasm; Renal Insufficiency; Squamous Cell Carcinoma of Head and Neck; Marijuana Abuse; Depressive Disorder, Major; Migraine Disorders; Neoplasms; Arthritis, Rheumatoid; Diabetic Neuropathies; Anxiety Disorders; Kidney Diseases; Anorexia; Essential Tremor; Opioid-Related Disorders; Neck Pain; Sleep Wake Disorders; Multiple Scler Details
Cannabidiol GWP-42003-P; BOL-DP-o-05; GW-42003; BTX-1204; ZYN-002; PTL-101; CHI-902; APH-1501; AVCN-583601; GLA-015; BTX-1503; BTX-1801; BTX-1702; PBX-1308; ART-12.11; ART-1211; RAD-011; BRCX-014; RLS-103; LYT-310; RAD011; GWP-42003 Approved Gw Pharmaceuticals Plc Cannepil, Zygel, Epidiolex, Epidyolex United States Epilepsies, Myoclonic; Lennox Gastaut Syndrome null 2018-06-25 Migraine Disorders; Peripheral Nervous System Diseases; Tobacco Use Cessation; Facial Pain; Marijuana Smoking; Ovarian Neoplasms; Acne Vulgaris; Tobacco Smoking; Substance-Related Disorders; Sleep Initiation and Maintenance Disorders; HIV Infections; Anxiety; Seizures; Tuberous Sclerosis; Schizophrenia; Marijuana Abuse; Rett Syndrome; Fatty Liver; Autism Spectrum Disorder; Child Behavior Disorders; Chronic Pain; Pain; Alcoholic Intoxication; Inflammatory Bowel Diseases; Marijuana Use; Diabetes Mellitus, Type 2; Appetitive Behavior; Brain Injuries, Traumatic; Spinal Cord Injuries; Depression; Opioid-Related Disorders; Bipolar Disorder; Dyspepsia; Psychotic Disorders; Brain Diseases; Blepharospasm; Coronavirus Disease 2019 (COVID-19); Musculoskeletal Pain; Neoplasms; Hyperalgesia; Sleep Wake Disorders; Chronic Urticaria; Graft vs Host Disease; Sturge-Weber Syndrome; Arthritis, Rheumatoid; Hoarding Disorder; Diabetic Neuropathies; Pancreatic Neoplasms; Dysmenorrhea; Glioblastoma; Schizophrenia Spectrum and Other Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Dronabinol(AXIM Biotechnologies) Phase 3 Clinical Axim Biotech Neoplasms; Child Nutrition Disorders; Vomiting; Nausea; Cachexia; Sarcopenia; Anorexia Nervosa Details
Adezunap AP-707 Phase 3 Clinical CannaXan GmbH Multiple Sclerosis; Accidental Injuries; Low Back Pain; Diabetes Mellitus; Peripheral Nerve Injuries; Diabetic peripheral neuropathy; Back Pain; Neuralgia; Somatoform Disorders; Stroke; Peripheral Nervous System Diseases; Brachial Plexus Neuropathies; Phantom Limb; Pain, Postoperative; Diabetic Neuropathies; Brain Injuries, Traumatic; Chronic Pain; Pain; Paraplegia Details
Dronabinol(Vertanical) VER-01 Phase 3 Clinical Vertanical GmbH Back Pain; Low Back Pain Details
V-24343 V-24343; ANEB-001 Phase 2 Clinical Vernalis Plc Poisoning; Obesity Details
11C-MePPEP 11C-MePPEP Phase 2 Clinical Eli Lilly And Company Substance-Related Disorders; Obesity Details
AX-1602 AX-1602 Phase 2 Clinical Axim Biotech Psoriasis; Dermatitis, Atopic; Vitiligo Details
Nimacimab RYI-018; RYI-028; JNJ-2463 Phase 2 Clinical Bird Rock Bio Inc Metabolic Dysfunction-Associated Steatotic Liver Disease; Renal Insufficiency, Chronic; Obesity; Diabetic Gastroparesis Details
ART-2713 NEO-1940; ART-2713; ART27.13; AZD-1940 Phase 2 Clinical Astrazeneca Plc, Neomed Inc, Pfizer Inc Weight Loss; Pain; Anorexia; Cachexia; Low Back Pain Details
Cannabidiol/hydroxychloroquine IHL-675A; IHL-675 Phase 2 Clinical Incannex Healthcare Ltd Arthritis, Rheumatoid; Respiratory Distress Syndrome, Adult Details
AEF-0217 AEF-0217 Phase 2 Clinical Aelis Farma Down Syndrome Details
Monlunabant MRI-1891; NN9440–INV-202; INV-202 Phase 2 Clinical Inversago Pharma Inc Metabolic Syndrome; Metabolic Diseases; Diabetic Nephropathies; Obesity Details
Cannabidiol/Palmitoylethanolamide THX-210; SCI–210 Phase 2 Clinical Therapix Biosciences Ltd Autism Spectrum Disorder; Diabetic Neuropathies Details
IGC-AD1 IGC-AD1 Phase 2 Clinical University Of South Florida Anxiety; Depression; Alzheimer Disease; Psychomotor Agitation; Memory Disorders Details
AEF-0117 AEF-0117 Phase 2 Clinical National Institute On Drug Abuse, Aelis Farma Marijuana Abuse Details
[11C]OMAR [11C]JHU-75528 Phase 1 Clinical Johns Hopkins University School Of Medicine Marijuana Abuse; Schizophrenia Details
ZYN-001 ZYN-001 Phase 1 Clinical Zynerba Pharmaceuticals Neuralgia; Fibromyalgia Details
Tetrahydrocannabivarin GWP-42004; THCV; O-4394; DELTA9-THCV; GW-42004 Phase 1 Clinical Gw Pharmaceuticals Plc Diabetes Mellitus, Type 2; Hyperglycemia; Metabolic Syndrome; Obesity, Morbid; Hypercholesterolemia; Dyslipidemias Details
Zevaquenabant MRI-1867; (S)-MRI-1867; INV-101 Phase 1 Clinical National Institutes Of Health Scleroderma, Systemic; Colitis, Ulcerative Details
IPI 201(Isosceles Pharmaceuticals Inc ) IPI-201 Phase 1 Clinical Pain, Postoperative Details
GFB-024 Phase 1 Clinical Takeda Pharma Kidney Diseases; Endocrine System Diseases; Diabetic Nephropathies; Diabetes Complications; Diabetes Mellitus Details
DBPR-211 Phase 1 Clinical National Health Research Institutes Diabetes Mellitus, Type 2 Details
MP-10X MP-10X Clinical Medipure Holdings Pain Details
C20T5 C20T5 Murdoch Childrens Research Institute Details
C12T12 C12T12 Murdoch Childrens Research Institute Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message